Janet Ford, MPH, PhD

Director Real-World Evidence, HEOR
Agios Pharmaceuticals, Inc.

Poster(s):

• (229) Mitapivat treatment usage, satisfaction and adherence among adults with pyruvate kinase deficiency in the United States
  Wednesday, October 29, 2025

• (231) Real-world impact on work and school among adults with pyruvate kinase deficiency in the United States
  Wednesday, October 29, 2025